| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7649ff2955ce2c04acb9134673c11e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4704 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-583 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-30 |
| filingDate |
2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34af9810d07a532bf40c3e5b219ce107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa261c395b8feae7b8196b0b9bab62f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e809b7791fabee48aa3f525f76d6da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afa2145a0b60cd7710b8f6e1925108b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc3cdf4f76ab9c45c693077b9c3ef8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9434ff69bf39c1cadcb1f604287d80c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c38ce141b05112787a5140cf5dd59a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22548f7fa03c7c3e4a677fc98677974e |
| publicationDate |
2019-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109406792-A |
| titleOfInvention |
Application and evaluation method of GPR65 protein in the preparation of glioblastoma prognosis evaluation kit |
| abstract |
The invention provides the application and evaluation method of GPR65 protein in the preparation of glioblastoma prognosis evaluation kit. The invention uses GPR65 protein as a molecular marker for evaluating the prognosis of glioblastoma patients for the first time. Methods The expression level of GPR65 protein in brain glioblastoma tissue was determined, and the prognosis of patients with brain glioblastoma was judged according to the comprehensive score of GPR65 protein relative expression in cytoplasm. The risk of recurrence and the survival time of patients after surgery provide a new approach. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114516916-A |
| priorityDate |
2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |